Table of ContentsView AllTable of ContentsSymptomsCausesDiagnosisTreatment
Table of ContentsView All
View All
Table of Contents
Symptoms
Causes
Diagnosis
Treatment
This metabolic dysfunction leads to a buildup of methylmalonic acid in the body. Methylmalonic acidemia can cause coma and other serious symptoms if not correctly diagnosed and treated.
This article explains the symptoms of methylmalonic acidemia and how it is passed down within families. It also discusses how MMA is diagnosed and treated, along with some of the long-term impacts.
Verywell / JR Bee
Symptoms of Methylmalonic Acidemia
Methylmalonic acidemia is a complex disease that can cause a variety of different symptoms.The intensity of these symptoms varies based on the exact genetic mutation causing the disease.
In the most severe cases, symptoms begin almost immediately at birth. In others, they might not appear until later infancy, childhood, or even adulthood.
Called “decompensation” of the illness, this may lead to life-threatening symptoms. For example, an infant undergoing a decompensation might experience:
This can happen with even with the best medical interventions. Infants are particularly at risk.
Methylmalonic acidemia can lead to serious long-term health conditions as well, including:
Additional symptoms and conditions are possible as well. But it’s important to note that not everyone with MMA will have them all, or experience them at all times. For example, someone with a mild form of methylmalonic acidemia might first experience kidney disease symptoms in adulthood.
What Causes Methylmalonic Acidemia?
Methylmalonic acidemia belongs in a group of disorders known asinborn errors of metabolism.
Metabolism takes place through a complicated and highly coordinated sequence of chemical reactions. Problems in many different genes may disrupt normal metabolic processes.
Methylmalonic acidemia also belongs to a smaller subset of these diseases, termedorganic acidurias.These genetic diseases result from difficulties metabolizing certain types of amino acids, the building blocks of proteins. It results in unhealthy levels of products otherwise normally present in the body.
Defects in different enzymes lead to different types of organic aciduria. For example,propionic acidemiais another rare disease in this class.Other rare diseases in this group may have some similar symptoms.
Gene Defects in MMA
In more than 60% of cases, the cause is:
Because the function of a key enzyme is impaired with methylmalonic acidemia, the specific amino acid and related compounds found in fats and cholesterol build up to toxic levels and cause symptoms of the disorder, including interference with producing energy for the body.
How MMA Is Passed Down
Methylmalonic acidemia is an autosomal recessive genetic condition.This means that a person has to inherit an affected gene from both of their parents to get the disease.
If a couple has had one child born with methylmalonic acidemia, there is a 25% chance that their next child would also have the condition.It’s also important to test existing siblings for the disease since not all people with MMA display symptoms right away.
Early diagnosis and management may then help prevent long-term complications from the disease. Talking with a genetic counselor can be very helpful for many families. This can give you a sense of the risks in your situation. Prenatal testing may also be an option.
The standard newborn screening tests sometimes provide the diagnosis of methylmalonic acidemia.However, not all places test for this specific disease. Also, infants might first experience symptoms before the results of these screening tests are available.
Diagnosis of methylmalonic acidemia requires a thorough medical history and exam. Laboratory testing is critical as well. It’s important that diagnosis happens as quickly as possible since affected individuals are often very ill. Also, untreated decompensations can worsen the long-term complications of MMA (for example, causing permanent brain damage).
Many different types of medical problems can lead to neurological and other symptoms such as those seen in decompensated methylmalonic acidemia. It can be a challenge to rule out these other possible diagnoses and narrow down on the specific cause. Since MMA is a rare condition, a medical specialist may be needed to help diagnose the disease.
One key diagnostic test for MMA looks at how much methylmalonic acid is present in the blood or urine.
In people with MMA, these levels should be higher than usual. However, there are also some other different inborn errors of metabolism that can cause methylmalonic acid to build up as a result of different genetic problems.
Blood tests that may be helpful in diagnosing methylmalonic acidemia include:
Additionalgenetic testscan help finalize the diagnosis and can also identify the specific genetic mutation involved. In some cases, this may affect treatment options.
How MMA Is Treated
The treatment for methylmalonic acidemia depends on a person’s history with the disorder and their specific symptoms. These options vary according to whether the needed treatment is immediate because of an emergency context, or if they’re meant for long-term care.
Emergency Treatment
Periods of decompensations from methylmalonic acidemia are medical emergencies.Without support in this time, individuals may die. These periods might happen before an initial diagnosis or at other times of stress or illness. Intensive support in a hospital setting is necessary.
Some interventions that might be needed during an emergency include:
Diet
Dietary management is an important part of treatment for methylmalonic acidemia. A dietary specialist who is experienced in rare metabolic diseases can help guide nutritional support.
Reducing the amount of protein consumed may reduce the impact of the disease.
However, limiting protein too severely has its own negative health impacts. That’s why it’s helpful to work with a professional. A feeding tube is also sometimes helpful to help ensure proper nutrition, especially during decompensations.
Long-Term Treatments
Injections of vitamin B12 (hydroxocobalamin) are a very helpful treatment for people with specific genetic subtypes of MMA, but not for all subtypes.
Other long-term medications might also be needed to treat complications. For example, someone might need to take a bisphosphonate drug to help treat osteoporosis related to methylmalonic acidemia.
Liver transplant is also an option for some people with MMA. It doesn’t cure the disease, but it can help a person experience less frequent and less severe decompensations.Kidney transplant might also be needed for people with severe kidney disease.
Preventing Decompensations
Preventing decompensations is also an important part of treatment. People with methylmalonic acidemia should not fast or increase their intake of protein because this might trigger a decompensation.
If an individual with MMA is ill, such as from a virus, it’s important that they decrease protein intake and receive additional fluids with sugar. This can help prevent a decompensation.
Affected individuals need to be closely monitored whenever they are exposed to stressors that might trigger a decompensation. That way, treatment can begin promptly if necessary.
Seek medical attention immediately if the person with methylmalonic acidemia has any unusual symptoms such as decreased wakefulness or if you have any other concerns about a decompensation.
Monitoring
People with methylmalonic acidemia also need regular monitoring for long-term complications of the condition.For example, this should include regular eye exams and tests of kidney function.
Ideally, people with MMA should see a specialist with experience in rare genetic diseases. Treatment and monitoring will require a range of medical professionals working together as a team.
New Potential Treatments
Ask your healthcare provider if you are interested in participating in a clinical trial. Or, check out the United States database for clinical trials.
A Word From Verywell
A diagnosis of methylmalonic acidemia can be challenging for many families. Fortunately, both diagnosis and treatment have improved in recent years.
MMA is a significant condition that will require long-term management, so be sure to reach out for support from family members, your healthcare team, and available support groups.
How Genetic Disorders Are Inherited
19 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
U.S. National Library of Medicine.Methylmalonic Acidemia - Genetics Home Reference - NIH.
Zhou X, Cui Y, Han J.Methylmalonic acidemia: Current status and research priorities.Intractable Rare Dis Res. 2018;7(2):73–78. doi:10.5582/irdr.2018.01026
Baumgartner MR, Hörster F, Dionisi-Vici C, et al.Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.Orphanet J Rare Dis. 2014;9:130. doi:10.1186/s13023-014-0130-8
Sheikhmoonesi F, Shafaat A, Moarefian S, Zaman T.Affective disorder as the first manifestation of methylmalonic acidemia: a case report.Iran J Pediatr. 2013;23(2):245–246. PMID:23724196
Fraser JL, Venditti CP.Methylmalonic and propionic acidemias: clinical management update.Curr Opin Pediatr. 2016;28(6):682–693. doi:10.1097/MOP.0000000000000422
Poretti A, Blaser SI, Lequin MH, et al.Neonatal neuroimaging findings in inborn errors of metabolism.J Magn Reson Imaging. 2013;37(2):294–312. doi:10.1002/jmri.23693
Alkhunaizi AM, Al-Sannaa N.Renal Involvement in Methylmalonic Aciduria.Kidney Int Rep. 2017;2(5):956–960. doi:10.1016/j.ekir.2017.04.007
Hu S, Kong X.The genotype analysis and prenatal genetic diagnosis among 244 pedigrees with methylmalonic aciduria in China.Taiwan J Obstet Gynecol. 2022 Mar;61(2):290-298. doi:10.1016/j.tjog.2022.02.017.
Riemersma M, Hazebroek MR, Helderman-van den Enden ATJM, et al.Propionic acidemia as a cause of adult-onset dilated cardiomyopathy.Eur J Hum Genet. 2017;25(11):1195–1201. doi:10.1038/ejhg.2017.127
Manoli I, Sloan JL, Venditti CP.Isolated Methylmalonic Acidemia. 2005 Aug 16. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
Chandler RJ, Venditti CP.Gene Therapy for Methylmalonic Acidemia: Past, Present, and Future. Hum Gene Ther. 2019;30(10):1236-1244. doi:10.1089/hum.2019.113
National Center for Biotechnology Information.Comprehensive Metabolism Panel - Tests - GTR - NCBI.
Koeth RA, Wang Z, Levison BS, et al.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.Nat Med. 2013;19(5):576–585. doi:10.1038/nm.3145
Jadlowiec CC, Taner T.Liver transplantation: Current status and challenges.World J Gastroenterol. 2016;22(18):4438–4445. doi:10.3748/wjg.v22.i18.4438
U.S. National Library of Medicine.Clinical Trials.
Manoli I, Venditti CP.Disorders of branched chain amino acid metabolism.Translational Science of Rare Diseases. 2016;1(2):91-110. doi:10.3233/TRD-160009
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
